Plain-English translation of NCT05179447 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to deciding what follow-up treatment women with early-stage endometrial cancer should receive after surgery. Instead of using only traditional factors like age and tumor grade, doctors will also look at the genetic profile of the cancer itself. By matching treatment to your cancer's specific genetic characteristics, the goal is to help women who truly need additional therapy get it, while sparing those who don't need it from unnecessary side effects.
Currently, many women with early-stage endometrial cancer receive follow-up treatments like radiation or chemotherapy based on older methods of assessing risk. However, newer genetic testing can reveal much more about how aggressive a cancer is and whether it will come back. This trial exists to find out whether using genetic information leads to better outcomes and fewer women being overtreated.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. One group will have genetic testing done on their cancer, and treatment (observation, vaginal radiation, or chemotherapy plus radiation) will be chosen based on those results. The other group will receive standard follow-up treatment based on traditional risk factors. You will likely have follow-up visits with your doctor to monitor your health and watch for any signs of cancer returning.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China